Literature DB >> 32238474

Tubular STAT3 Limits Renal Inflammation in Autosomal Dominant Polycystic Kidney Disease.

Amandine Viau1,2, Maroua Baaziz1,2, Amandine Aka1,2, Manal Mazloum1,2, Clément Nguyen1,2, E Wolfgang Kuehn3,4,5, Fabiola Terzi1,2, Frank Bienaimé6,2,7.   

Abstract

BACKGROUND: The inactivation of the ciliary proteins polycystin 1 or polycystin 2 leads to autosomal dominant polycystic kidney disease (ADPKD). Although signaling by primary cilia and interstitial inflammation both play a critical role in the disease, the reciprocal interactions between immune and tubular cells are not well characterized. The transcription factor STAT3, a component of the cilia proteome that is involved in crosstalk between immune and nonimmune cells in various tissues, has been suggested as a factor fueling ADPKD progression.
METHOD: To explore how STAT3 intersects with cilia signaling, renal inflammation, and cyst growth, we used conditional murine models involving postdevelopmental ablation of Pkd1, Stat3, and cilia, as well as cultures of cilia-deficient or STAT3-deficient tubular cell lines.
RESULTS: Our findings indicate that, although primary cilia directly modulate STAT3 activation in vitro, the bulk of STAT3 activation in polycystic kidneys occurs through an indirect mechanism in which primary cilia trigger macrophage recruitment to the kidney, which in turn promotes Stat3 activation. Surprisingly, although inactivating Stat3 in Pkd1-deficient tubules slightly reduced cyst burden, it resulted in a massive infiltration of the cystic kidneys by macrophages and T cells, precluding any improvement of kidney function. We also found that Stat3 inactivation led to increased expression of the inflammatory chemokines CCL5 and CXCL10 in polycystic kidneys and cultured tubular cells.
CONCLUSIONS: STAT3 appears to repress the expression of proinflammatory cytokines and restrict immune cell infiltration in ADPKD. Our findings suggest that STAT3 is not a critical driver of cyst growth in ADPKD but rather plays a major role in the crosstalk between immune and tubular cells that shapes disease expression.
Copyright © 2020 by the American Society of Nephrology.

Entities:  

Keywords:  ADPKD; STAT3; cilia; inflammation

Mesh:

Substances:

Year:  2020        PMID: 32238474      PMCID: PMC7217419          DOI: 10.1681/ASN.2019090959

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  56 in total

1.  Scattered Deletion of PKD1 in Kidneys Causes a Cystic Snowball Effect and Recapitulates Polycystic Kidney Disease.

Authors:  Wouter N Leonhard; Malu Zandbergen; Kimberley Veraar; Susan van den Berg; Louise van der Weerd; Martijn Breuning; Emile de Heer; Dorien J M Peters
Journal:  J Am Soc Nephrol       Date:  2014-10-31       Impact factor: 10.121

2.  Polycystin-1 regulates STAT activity by a dual mechanism.

Authors:  Jeffrey J Talbot; Jonathan M Shillingford; Shivakumar Vasanth; Nicholas Doerr; Sambuddho Mukherjee; Mike T Kinter; Terry Watnick; Thomas Weimbs
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

3.  Macrophage-secreted IL-8 induces epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2/STAT3/Snail pathway.

Authors:  Xiu-Tao Fu; Zhi Dai; Kang Song; Zhuo-Jun Zhang; Zheng-Jun Zhou; Shao-Lai Zhou; Yi-Ming Zhao; Yong-Sheng Xiao; Qi-Man Sun; Zhen-Bin Ding; Jia Fan
Journal:  Int J Oncol       Date:  2014-11-18       Impact factor: 5.650

4.  Deletion of intestinal epithelial cell STAT3 promotes T-lymphocyte STAT3 activation and chronic colitis following acute dextran sodium sulfate injury in mice.

Authors:  Tara A Willson; Ingrid Jurickova; Margaret Collins; Lee A Denson
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

5.  Beta4 integrin and laminin 5 are aberrantly expressed in polycystic kidney disease: role in increased cell adhesion and migration.

Authors:  Dominique Joly; Viviane Morel; Aurélie Hummel; Antonella Ruello; Patrick Nusbaum; Natacha Patey; Laure-Hélène Noël; Patricia Rousselle; Bertrand Knebelmann
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

6.  Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.

Authors:  Vicente E Torres; Arlene B Chapman; Olivier Devuyst; Ron T Gansevoort; Ronald D Perrone; Gary Koch; John Ouyang; Robert D McQuade; Jaime D Blais; Frank S Czerwiec; Olga Sergeyeva
Journal:  N Engl J Med       Date:  2017-11-04       Impact factor: 91.245

Review 7.  A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan.

Authors:  Fouad T Chebib; Ronald D Perrone; Arlene B Chapman; Neera K Dahl; Peter C Harris; Michal Mrug; Reem A Mustafa; Anjay Rastogi; Terry Watnick; Alan S L Yu; Vicente E Torres
Journal:  J Am Soc Nephrol       Date:  2018-09-18       Impact factor: 10.121

8.  Renal expression of JAK2 is high in polycystic kidney disease and its inhibition reduces cystogenesis.

Authors:  Foteini Patera; Alex Cudzich-Madry; Zhi Huang; Maria Fragiadaki
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

9.  Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease.

Authors:  Ming Ma; Xin Tian; Peter Igarashi; Gregory J Pazour; Stefan Somlo
Journal:  Nat Genet       Date:  2013-07-28       Impact factor: 38.330

10.  Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat.

Authors:  Eve-Irene Lepist; Xuexiang Zhang; Jia Hao; Jane Huang; Alan Kosaka; Gabriel Birkus; Bernard P Murray; Roy Bannister; Tomas Cihlar; Yong Huang; Adrian S Ray
Journal:  Kidney Int       Date:  2014-03-19       Impact factor: 10.612

View more
  4 in total

Review 1.  The Controversial Role of Fibrosis in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Maria Fragiadaki; Fiona M Macleod; Albert C M Ong
Journal:  Int J Mol Sci       Date:  2020-11-25       Impact factor: 5.923

2.  Ppia is the most stable housekeeping gene for qRT-PCR normalization in kidneys of three Pkd1-deficient mouse models.

Authors:  Juan J Muñoz; Ana C Anauate; Luiz F Onuchic; Ita P Heilberg; Andressa G Amaral; Frederico M Ferreira; Elieser H Watanabe; Renata Meca; Milene S Ormanji; Mirian A Boim
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379

3.  Heterogeneity of cell composition and origin identified by single-cell transcriptomics in renal cysts of patients with autosomal dominant polycystic kidney disease.

Authors:  Qiong Li; Yuchen Wang; Wenfeng Deng; Yanna Liu; Jian Geng; Ziyan Yan; Fei Li; Binshen Chen; Zhuolin Li; Renfei Xia; Wenli Zeng; Rumin Liu; Jian Xu; Fu Xiong; Chin-Lee Wu; Yun Miao
Journal:  Theranostics       Date:  2021-11-01       Impact factor: 11.556

4.  The carboxy-terminus of the human ARPKD protein fibrocystin can control STAT3 signalling by regulating SRC-activation.

Authors:  Claudia Dafinger; Amrei M Mandel; Alina Braun; Heike Göbel; Kathrin Burgmaier; Laura Massella; Antonio Mastrangelo; Jörg Dötsch; Thomas Benzing; Thomas Weimbs; Bernhard Schermer; Max C Liebau
Journal:  J Cell Mol Med       Date:  2020-10-28       Impact factor: 5.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.